Literature DB >> 17998553

Validation of tissue microarrays for immunohistochemical analyses of canine lymphomas.

Stefan M Keller1, Barbara C Keller, Paula Grest, Claas T Börger, Franco Guscetti.   

Abstract

In most validation studies of tissue microarrays (TMAs), a fixed number of cores with a given diameter are analyzed to determine the degree of accuracy by which the TMA represents the whole section. The statistical model described in the present study predicts this property for various combinations of 2 core sizes (0.6 mm and 1.2 mm) and different core numbers. The model was based on artificial TMA core biopsies generated from Ki-67 and active caspase-3 immunostains of 40 canine lymphoma samples. Positivity was scored on a continuous scale, and a large number of cells were analyzed with the help of semiautomated cell counting. Despite considerable differences in range and distribution of Ki-67 and active caspase-3 positivity values, the model predictions showed a high degree of agreement for both markers. Comparison of 0.6 mm and 1.2 mm cores indicated that the use of small cores necessitates inclusion of a larger number of samples but requires counting a markedly smaller number of cells. Suitability of TMAs to determine the immunophenotype of the whole section was assessed using 2 different combinations of core sizes and numbers. Both displayed a high degree of concordance with the whole section (kappa(0.6) = 0.79; kappa(1.2) = 0.91). The present study provides a basis for the use of TMAs in future high-throughput immunohistochemical investigations of selected markers in canine lymphomas. The statistical model presented can be used to determine an optimal TMA design depending on a desired accuracy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998553     DOI: 10.1177/104063870701900606

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  2 in total

1.  Hypoxia-Related Marker GLUT-1, CAIX, Proliferative Index and Microvessel Density in Canine Oral Malignant Neoplasia.

Authors:  Valeria Meier; Franco Guscetti; Malgorzata Roos; Stefanie Ohlerth; Martin Pruschy; Carla Rohrer Bley
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

2.  Evaluation of the Proliferative Activity of Diffuse Large B-Cell Lymphoma (DLBCL) in Dogs with Respect to Patient Eligibility for Anthracycline-Based Chemotherapy.

Authors:  Paweł Klimiuk; Wojciech Łopuszyński; Kamila Bulak; Adam Brzana
Journal:  Animals (Basel)       Date:  2021-04-20       Impact factor: 2.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.